Molecular pathogenesis of euthyroid and toxic multinodular goiter

Endocrine Reviews

Volumn 26, Issue 4, 2005, Pages 504-524

  Krohn, Knut ^a,b   Führer, Dagmar ^a   Bayer, Yvonne ^a   Eszlinger, Markus ^a   Brauer, Volker ^a   Neumann, Susanne ^a   Paschke, Ralf ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODIDE; LEVOTHYROXINE; RADIOACTIVE IODINE; THYROTROPIN RECEPTOR;

CHROMOSOME ABERRATION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DNA MICROARRAY; EUTHYROID MULTINODULAR GOITER; EUTHYROIDISM; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GOITER; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MUTAGENESIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCINTISCANNING; SIGNAL TRANSDUCTION; SOMATIC MUTATION; THYROID HYPERPLASIA; THYROID TUMOR; TOXIC GOITER;

ANIMALS; BIOLOGICAL TRANSPORT; CHROMOSOME ABERRATIONS; GOITER, NODULAR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IODIDES; LINKAGE (GENETICS); MUTATION; PROTEIN ARRAY ANALYSIS; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; THYROID GLAND;

EID: 20044374286     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2004-0005     Document Type: Review

References (307)

1. Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908-911
2. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R 1992 Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363-369
3. Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H, Jorgensen T 2000 Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 142:224-230
4. Berghout A, Wiersinga WM, Smits NJ, Touber JL 1990 Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 89:602-608
5. Vassart G, Dumont JE 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596-611
6. Dumont JE, Lamy F, Roger P, Maenhaut C 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667-697
7. Paschke R, Ludgate M 1997 The thyrotropin receptor in thyroid diseases. N Engl J Med 337:1675-1681
8. Krohn K, Paschke R 2001 Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 86:3336-3345
9. Krohn K, Wohlgemuth S, Gerber H, Paschke R 2000 Hot microscopic areas of iodine deficient euthyroid goiters contain constitutively activating TSH receptor mutations. J Pathol 192:37-42
10. Ledent C, Coppee F, Dumont JE, Vassart G, Parmentier M 1996 Transgenic models for proliferative and hyperfunctional thyroid diseases. Exp Clin Endocrinol Diabetes 104(Suppl 3):43-46
11. Delange F 1994 The disorders induced by iodine deficiency. Thyroid 4:107-128
12. Delange F, de Benoist B, Pretell E, Dunn JT 2001 Iodine deficiency in the world: where do we stand at the turn of the century? Thyroid 11:437-447
13. Jarlov AE, Nygaard B, Hegedüs L, Hartling SG, Hansen JM 1998 Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. Thyroid 8:393-398
14. Tan GH, Gharib H 1997 Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226-231
15. Hegedüs L 2001 Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339-344
16. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H 2000 Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf) 53:479-485
17. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A 1999 The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84:561-566
18. Hampel R, Kulberg T, Klein K, Jerichow JU, Pichmann EG, Clausen V, Schmidt I 1995 [Goiter incidence in Germany is greater than previously suspected]. Med Klin (Munich) 90:324-329 (German)
19. Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T 2002 Risk factors for goiter and thyroid nodules. Thyroid 12:879-888
20. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Hasan DM, Rodgers H, Tunbridge F 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55-68
21. Gärtner R, Bechtner G, Rafferzeder M, Greil W 1997 Comparison of urinary iodine excretion and thyroid volume in students with or without constant iodized salt intake. Exp Clin Endocrinol Diabetes 105(Suppl 4):43-45
22. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G 1991 High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 229:415-420
23. Hamburger JI 1980 Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 50:1089-1093
24. Baltisberger BL, Minder CE, Bürgi H 1995 Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol 132:546-549
25. Christensen SB, Ericsson UB, Janzon L, Tibblin S, Melander A 1984 Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. J Clin Endocrinol Metab 58:615-618
26. Knudsen N, Bulow I, Laurberg P, Ovesen L, Perrild H, Jorgensen T 2002 Association of tobacco smoking with goiter in a low-iodine-intake area. Arch Intern Med 162:439-443
27. Nagataki S, Nystrom E 2002 Epidemiology and primary prevention of thyroid cancer. Thyroid 12:889-896
28. Kazakov VS, Demidchik EP, Astakhova LN 1992 Thyroid cancer after Chernobyl. Nature 359:21
29. Shibata Y, Yamashita S, Masyakin VB, Panasyuk GD, Nagataki S 2001 15 Years after Chernobyl: new evidence of thyroid cancer. Lancet 358:1965-1966
30. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice Jr JD 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277
31. Hahn K, Schnell-Inderst P, Grosche B, Holm LE 2001 Thyroid cancer after diagnostic administration of iodine-131 in childhood. Radiat Res 156:61-70
32. Sari R, Balci MK, Altunbas H, Karayalcin U 2003 The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol (Oxf) 59:258-262
33. Hegedüs L, Bonnema SJ, Bennedbaek FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132
34. Reinwein D, Benker G, Konig MP, Pinchera A, Schatz H, Schleusener A 1988 The different types of hyperthyroidism in Europe. Results of a prospective survey of 924 patients. J Endocrinol Invest 11:193-200
35. Furlanetto TW, Nguyen LQ, Jameson JL 1999 Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 140:5705-5711
36. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M 2001 Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86:1072-1077
37. Struve C, Ohlen S 1990 [The effect of earlier pregnancies on the prevalence of goiter and nodules in thyroid-healthy women]. Dtsch Med Wochenschr 115:1050-1053 (German)
38. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG 1996 Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156:2165-2172
39. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559
40. Blum M, Hussain MA 2003 Evidence and thoughts about thyroid nodules that grow after they have been identified as benign by aspiration cytology. Thyroid 13:637-641
41. Giuffrida D, Gharib H 1995 Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 99:642-650
42. Trivalle C, Doucet J, Chassagne P, Landrin I, Kadri N, Menard JF, Bercoff E 1996 Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 44:50-53
43. Toft AD 2001 Clinical practice. Subclinical hyperthyroidism. N Engl J Med 345:512-516
44. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865
45. Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J, Vassart G 1994 Germline mutations in the thyrotropin receptor gene cause nonautoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396-401
46. 463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Thyroid 10:1035-1041
47. Kraiem Z, Glaser B, Yigla M, Pauker J, Sadeh O, Sheinfeld M 1987 Toxic multinodular goiter: a variant of autoimmune hyperthyroidism. J Clin Endocrinol Metab 65:659-664
48. Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R 2001 Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Horm Metab Res 33:504-507
49. Meller J, Jauho A, Hufner M, Gratz S, Becker W 2000 Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid 10:1073-1079
50. Brander AE, Viikinkoski VP, Nickels JI, Kivisaari LM 2000 Importance of thyroid abnormalities detected at US screening: a 5-year follow-up. Radiology 215:801-806
51. Alexander EK, Hurwitz S, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Larsen PR, Marqusee E 2003 Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 138:315-318
52. Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Morita S, Miyauchi A, Katayama S, Sugawara M 1992 Outcome of long standing solitary thyroid nodules. World J Surg 16:583-587
53. Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M 1994 Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 18:495-498
54. Manz F, Bohmer T, Gartner R, Grossklaus R, Klett M, Schneider R 2002 Quantification of iodine supply: representative data on intake and urinary excretion of iodine from the German population in 1996. Ann Nutr Metab 46:128-138
55. Quadbeck B, Pruellage J, Roggenbuck U, Hirche H, Janssen OE, Mann K, Hoermann R 2002 Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diabetes 110:348-354
56. Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM 1998 Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780-783
57. Wemeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C, Vlaeminck-Guillem V 2002 Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87:4928-4934
58. Bähre M, Hilgers R, Lindemann C, Emrich D 1988 Thyroid autonomy: sensitive detection in vivo and estimation of its functional relevance using quantified high-resolution scintigraphy. Acta Endocrinol (Copenh) 117:145-153
59. Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D 1993 Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 128:51-55
60. Elte JW, Bussemaker JK, Haak A 1990 The natural history of euthyroid multinodular goitre. Postgrad Med J 66:186-190
61. Wiener JD 1987 Long-term follow-up in untreated Plummer's disease (autonomous goiter). Clin Nucl Med 12:198-203
62. Emrich D, Erlenmaier U, Pohl M, Luig H 1993 Determination of the autonomously functioning volume of the thyroid. Eur J Nucl Med 20:410-414
63. Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, Vidor G, Braverman LE, Medeiros-Neto G 1998 Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 8:83-100
64. Reinwein D, Benker G, Konig MP, Pinchera A, Schatz H, Schleusener H 1986 Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentric survey. J Endocrinol Invest 9(Suppl 2):1-36
65. Thomas GA, Williams D, Williams ED 1989 Clonal origin of thyroid tumours. In: Wynford-Thomas D, Williams ED, eds. Thyroid tumors. Molecular basis of pathogenesis. London: Churchill Livingstone; 38-56
66. Vogelstein B, Fearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, Riggs AD, Orkin SH 1987 Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 47:4806-4813
67. Namba H, Matsuo K, Fagin JA 1990 Clonal composition of benign and malignant human thyroid tumors. J Clin Invest 86:120-125
68. Aeschimann S, Kopp PA, Kimura ET, Zbaeren J, Tobler A, Fey MF, Studer H 1993 Morphological and functional polymorphism within clonal thyroid nodules. J Clin Endocrinol Metab 77:846-851
69. Fey MF, Peter HJ, Hinds HL, Zimmermann A, Liechti-Gallati S, Gerber H, Studer H, Tobler A 1992 Clonal analysis of human tumors with M27β, a highly informative polymorphic X chromosomal probe. J Clin Invest 89:1438-1444
70. Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Fey MF, Studer H 1994 Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 79:134-139
71. Hicks DG, LiVolsi VA, Neidich JA, Puck JM, Kant JA 1990 Clonal analysis of solitary follicular nodules in the thyroid. Am J Pathol 137:553-562
72. Levy A 2001 Monoclonality of endocrine tumours: what does it mean? Trends Endocrinol Metab 12:301-307
73. Novelli M, Cossu A, Oukrif D, Quaglia A, Lakhani S, Poulsom R, Sasieni P, Carta P, Contini M, Pasca A, Palmieri G, Bodmer W, Tanda F, Wright N 2003 X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc Natl Acad Sci USA 100:3311-3314
74. Romert P, Gauguin J 1973 The early development of the median thyroid gland of the mouse. A light-, electron-microscopic and histochemical study. Z Anat Entwicklungsgesch 139:319-336
75. Lyon MF 1972 X-chromosome inactivation and developmental patterns in mammals. Biol Rev Camb Philos Soc 47:1-35
76. Levy A 2000 Is monoclonality in pituitary adenomas synonymous with neoplasia? Clin Endocrinol (Oxf) 52:393-397
77. Thomas GA, Williams D, Williams ED 1988 The demonstration of tissue clonality by X-linked enzyme histochemistry. J Pathol 155:101-108
78. Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK 2003 Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. J Clin Endocrinol Metab 88:3284-3291
79. Many MC, Denef JF, Hamudi S, Cornette C, Haumont S, Beckers C 1986 Effects of iodide and thyroxine on iodine-deficient mouse thyroid: a morphological and functional study. J Endocrinol 110:203-210
80. Stübner D, Gärtner R, Greil W, Gropper K, Brabant G, Permanetter W, Horn K, Pickardt CR 1987 Hypertrophy and hyperplasia during goitre growth and involution in rats-separate bioeffects of TSH and iodine. Acta Endocrinol (Copenh) 116:537-548
81. Wynford-Thomas D, Stringer BM, Williams ED 1982 Dissociation of growth and function in the rat thyroid during prolonged goitrogen administration. Acta Endocrinol (Copenh) 101:210-216
82. Ledent C, Dumont JE, Vassart G, Parmentier M 1992 Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J 11:537-542
83. Ledent C, Franc B, ParmentierM1998 [Transgenic mouse models. Their interest in thyroid tumors]. Arch Anat Cytol Pathol 46:31-37 (French)
84. Krohn K, Fuhrer D, Holzapfel HP, Paschke R 1998 Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab 83:130-134
85. Krohn K, Reske A, Ackermann F, Paschke R 2001 Ras mutations are rare in solitary cold and toxic thyroid nodules. Clin Endocrinol (Oxf) 55:241-248
86. sα mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684-691
87. Knudson AG 1973 Mutation and human cancer. Adv Cancer Res 17:317-352
88. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, Schultz G 1996 The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA 93:116-120
89. 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab 79:152-159
90. Allgeier A, Laugwitz KL, Van Sande J, Schultz G, Dumont JE 1997 Multiple G-protein coupling of the dog thyrotropin receptor. Mol Cell Endocrinol 127:81-90
91. Pisarev MA, DeGroot LJ, Wilber JF 1970 Cyclic-AMP production of goiter. Endocrinology 87:339-342
92. Roger PP, Hotimsky A, Moreau C, Dumont JE 1982 Stimulation by thyrotropin, cholera toxin and dibutyryl cyclic AMP of the multiplication of differentiated thyroid cells in vitro. Mol Cell Endocrinol 26:165-176
93. Wynford-Thomas D, Stringer BM, Harach HR, Williams ED 1983 Control of growth in the rat thyroid-an example of specific desensitization to trophic hormone stimulation. Experientia 39:421-423
94. Dumont JE, Roger P, Van Heuverswyn B, Erneux C, Vassart G 1984 Control of growth and differentiation by known intracellular signal molecules in endocrine tissues: the example of the thyroid gland. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:337-342
95. Roger P, Taton M, Van Sande J, Dumont JE 1988 Mitogenic effects of thyrotropin and adenosine 3′,5′-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 66:1158-1165
96. Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R, Feunteun J 1994 Oncogenic potential of guanine nucleotide stimulatory factor α subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA 91:10488-10492
97. Zeiger MA, Saji M, Gusev Y, Westra WH, Takiyama Y, Dooley WC, Kohn LD, Levine MA 1997 Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology 138:3133-3140
98. Nguyen LQ, Kopp P, Martinson F, Stanfield K, Roth SI, Jameson JL 2000 A dominant negative CREB (cAMP response elementbinding protein) isoform inhibits thyrocyte growth, thyroid-specific gene expression, differentiation, and function. Mol Endocrinol 14:1448-1461
99. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R 2002 Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 99:15462-15467
100. Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF 2002 Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA 99:15776-15781
101. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651
102. sα protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885-3891
103. Führer D, Kubisch C, Scheibler U, Lamesch P, Krohn K, Paschke R 1998 The extracellular thyrotropin receptor domain is not a major candidate for mutations in toxic thyroid nodules. Thyroid 8:997-1001
104. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655-659
105. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog 4:345-349
106. sα genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 82:2695-2701
107. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 79:1785-1789
108. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab 79:657-661
109. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JA, Caillou B, Monier R, Rapoport B, Filetti S 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 80:1347-1351
110. Russo D, Arturi F, Suarez HG, Schlumberger M, Du VJ, Crocetti U, Filetti S 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 81:1548-1551
111. Vanvooren V, Uchino S, Duprez L, Costa MJ, Vandekerckhove J, Parma J, Vassart G, Dumont JE, Van Sande J, Noguchi S 2002 Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. Eur J Endocrinol 147:287-291
112. Georgopoulos NA, Sykiotis GP, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Papavassiliou AG, Vagenakis AG 2003 Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Eur J Endocrinol 149:287-292
113. Arturi F, Scarpelli D, Coco A, Sacco R, Bruno R, Filetti S, Russo D 2003 Thyrotropin receptor mutations and thyroid hyperfunctioning adenomas ten years after their first discovery: unresolved questions. Thyroid 13:341-343
114. Vassart G 2004 Activating mutations of the TSH receptor. Thyroid 14:86-87
115. Garcia-Delgado M, Gonzalez-Navarro CJ, Napal MC, Baldonado C, Vizmanos JL, Gullon A 1998 Higher sensitivity of denaturing gradient gel electrophoresis than sequencing in the detection of mutations in DNA from tumor samples. Biotechniques 24:72, 74, 76
116. Fischer SG, Lerman LS 1983 DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci USA 80:1579-1583
117. Trülzsch B, Krohn K, Wonerow P, Paschke R 1999 DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. Biotechniques 27:266-268
118. Eszlinger M, Krohn K, Frenzel R, Kropf S, Tonjes A, Paschke R 2004 Gene expression analysis reveals evidence for inactivation of the TGF-β signaling cascade in autonomously functioning thyroid nodules. Oncogene 23:795-804
119. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X 2001 ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8:781-794
120. Deleu S, Allory Y, Radulescu A, Pirson I, Carrasco N, Corvilain B, Salmon I, Franc B, Dumont JE, Van Sande J, Maenhaut C 2000 Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid 10:131-140
121. Mezosi E, Yamazaki H, Bretz JD, Wang SH, Arscott PL, Utsugi S, Gauger PG, Thompson NW, Baker Jr JR 2002 Aberrant apoptosis in thyroid epithelial cells from goiter nodules. J Clin Endocrinol Metab 87:4264-4272
122. Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ 1996 RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunits. Nature 383:172-175
123. Freedman NJ, Lefkowitz RJ 1996 Desensitization of G protein-coupled receptors. Recent Prog Horm Res 51:319-353
124. 505Asn-activating thyrotropin-receptor germline mutation. Thyroid 9:757-761
125. Voigt C, Holzapfel H, Paschke R 2000 Expression of β-arrestins in toxic and cold thyroid nodules. FEBS Lett 486:208-212
126. Voigt C, Holzapfel HP, Meyer S, Paschke R 2004 Increased expression of G-protein coupled receptor kinases 3 and 4 in hyperfunctioning thyroid nodules. J Endocrinol 182:173-182
127. Biebermann H, Schoneberg T, Schulz A, Krause G, Gruters A, Schultz G, Gudermann T 1998 A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J 12:1461-1471
128. Park Y, Park E, Kim M, Kim T, Lee H, Lee S, Jang I, Shong M, Park D, Cho B 2002 Involvement of the protein kinase C pathway in thyrotropin-induced STAT3 activation in FRTL-5 thyroid cells. Mol Cell Endocrinol 194:77-84
129. Park ES, Kim H, Suh JM, Park SJ, You SH, Chung HK, Lee KW, Kwon OY, Cho BY, Kim YK, Ro HK, Chung J, Shong M 2000 Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway. Mol Endocrinol 14:662-670
130. Dumont JE, Maenhaut C, Pirson I, Baptist M, Roger PP 1991 Growth factors controlling the thyroid gland. Baillieres Clin Endocrinol Metab 5:727-754
131. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577-2585
132. Brenner-Gati L, Berg KA, Gershengorn MC 1989 Insulin-like growth factor-I potentiates thyrotropin stimulation of adenylyl cyclase in FRTL-5 cells. Endocrinology 125:1315-1320
133. Dugrillon A, Bechtner G, Uedelhoven WM, Weber PC, Gärtner R 1990 Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3′,5′-monophosphate formation. Endocrinology 127:337-343
134. Gartner R 1992 Thyroid growth in vitro. Exp Clin Endocrinol 100:32-35
135. Roger PP, Servais P, Dumont JE 1983 Stimulation by thyrotropin and cyclic AMP of the proliferation of quiescent canine thyroid cells cultured in a defined medium containing insulin. FEBS Lett 157:323-329
136. Smith P, Wynford-Thomas D, Stringer BM, Williams ED 1986 Growth factor control of rat thyroid follicular cell proliferation. Endocrinology 119:1439-1445
137. Eggo MC, Bachrach LK, Burrow GN 1990 Interaction of TSH, insulin and insulin-like growth factors in regulating thyroid growth and function. Growth Factors 2:99-109
138. Gärtner R, Schopohl D, Schaefer S, Dugrillon A, Erdmann A, Toda S, Bechtner G 1997 Regulation of transforming growth factor β1 messenger ribonucleic acid expression in porcine thyroid follicles in vitro by growth factors, iodine, or δ-iodolactone. Thyroid 7:633-640
139. Pang XP, Park M, Hershman JM 1992 Transforming growth factor-β blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells. Endocrinology 131:45-50
140. Taton M, Lamy F, Roger PP, Dumont JE 1993 General inhibition by transforming growth factor β1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol Cell Endocrinol 95:13-21
141. Colletta G, Cirafici AM, Di Carlo A 1989 Dual effect of transforming growth factor β on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reduction of thyroid-specific differentiation markers. Cancer Res 49:3457-3462
142. kip1. Mol Biol Cell 11:1061-1076
143. Grubeck-Loebenstein B, Buchan G, Sadeghi R, Kissonerghis M, Londei M, Turner M, Pirich K, Roka R, Niederle B, Kassal H 1989 Transforming growth factor β regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J Clin Invest 83:764-770
144. Tsushima T, Arai M, Saji M, Ohba Y, Murakami H, Ohmura E, Sato K, Shizume K 1988 Effects of transforming growth factor-β on deoxyribonucleic acid synthesis and iodine metabolism in porcine thyroid cells in culture. Endocrinology 123:1187-1194
145. Krohn K, Emmrich P, Ott N, Paschke R 1999 Increased thyroid epithelial cell proliferation in toxic thyroid nodules. Thyroid 9:241-246
146. Eggo MC,King WJ, Black EG, Sheppard MC 1996 Functional human thyroid cells and their insulin-like growth factor-binding proteins: regulation by thyrotropin, cyclic 3′,5′ adenosine monophosphate, and growth factors. J Clin Endocrinol Metab 81:3056-3062
147. Eszlinger M, Krohn K, Paschke R 2001 Complementary DNA expression array analysis suggests a lower expression of signal transduction proteins and receptors in cold and hot thyroid nodules. J Clin Endocrinol Metab 86:4834-4842
148. Derwahl M, Studer H 2001 Nodular goiter and goiter nodules: where iodine deficiency falls short of explaining the facts. Exp Clin Endocrinol Diabetes 109:250-260
149. Studer H, Peter HJ, Gerber H 1989 Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev 10:125-135
150. Ponder BA 2001 Cancer genetics. Nature 411:336-341
151. Albertson DG, Collins C, McCormick F, Gray JW 2003 Chromosome aberrations in solid tumors. Nat Genet 34:369-376
152. Gimm O 2001 Thyroid cancer. Cancer Lett 163:143-156.
153. Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW, Harris PE 1999 Prevalence of Ras mutations in thyroid neoplasia. Clin Endocrinol (Oxf) 50:529-535
154. Bos JL 1989 ras oncogenes in human cancer: a review. Cancer Res [Erratum (1990) 50:1352] 49:4682-4689
155. Wynford-Thomas D 1997 Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res 47:145-157
156. Kim DS, McCabe CJ, Buchanan MA, Watkinson JC 2003 Oncogenes in thyroid cancer. Clin Otolaryngol 28:386-395
157. Paschke R, Neumann S 2001 Sodium/iodide symporter mRNA expression in cold thyroid nodules. Exp Clin Endocrinol Diabetes 109:45-46
158. - symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab 86:2697-2700
159. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N 2003 The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48-77
160. Neumann S, Schuchardt K, Reske A, Reske A, Emmrich P, Paschke R 2004 Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules. Thyroid 14:99-111
161. Joba W, Spitzweg C, Schriever K, Heufelder AE 1999 Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases. Thyroid 9:455-466
162. Russo D, Bulotta S, Bruno R, Arturi F, Giannasio P, Derwahl M, Bidart JM, Schlumberger M, Filetti S 2001 Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter. Eur J Endocrinol 145:591-597
163. - symporter gene in human thyroid tumors: a comparison study with other thyroidspecific genes. J Clin Endocrinol Metab 84:3228-3234
164. Knauf JA, Kuroda H, Basu S, Fagin JA 2003 RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase. Oncogene 22:4406-4412
165. Trapasso F, Iuliano R, Chiefari E, Arturi F, Stella A, Filetti S, Fusco A, Russo D 1999 Iodide symporter gene expression in normal and transformed rat thyroid cells. Eur J Endocrinol 140:447-451
166. - symporter gene. Biochem Biophys Res Commun 239:34-41
167. Spitzweg C, Morris JC 2002 The sodium iodide symporter: its pathophysiological and therapeutic implications. Clin Endocrinol (Oxf) 57:559-574
168. Paschke R, Neumann S 2001 Clinical, epidemiologic and molecular evidence for a genetic etiology of a subset of euthyroid goiters. In: Duntas LH, ed. Bronchocele goiter. Goitrogenesis upon the advent of the new millennium. Athens: BETA Medical Publishers Ltd.; 43-49
169. Tonacchera M, Viacava P, Agretti P, de Marco G, Perri A, di Cosmo C, De Servi M, Miccoli P, Lippi F, Naccarato AG, Pinchera A, Chiovato L, Vitti P 2002 Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. J Clin Endocrinol Metab 87:352-357
170. Dunn JT, Dunn AD 2001 Update on intrathyroidal iodine metabolism. Thyroid 11:407-414
171. Caillou B, Dupuy C, Lacroix L, Nocera M, Talbot M, Ohayon R, Deme D, Bidart JM, Schlumberger M, Virion A 2001 Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. J Clin Endocrinol Metab 86:3351-3358
172. De Vijlder JJ 2003 Primary congenital hypothyroidism: defects in iodine pathways. Eur J Endocrinol 149:247-256
173. Gärtner R, Dugrillon A, Bechtner G 1990 Evidence that thyroid growth autoregulation is mediated by an iodolactone. Acta Med Austriaca 17(Suppl 1):24-26
174. Pisarev MA, Krawiec L, Juvenal GJ, Bocanera LV, Pregliasco LB, Sartorio G, Chester HA 1994 Studies on the goiter inhibiting action of iodolactones. Eur J Pharmacol 258:33-37
175. Krohn K, Paschke R 2001 Loss of heterozygosity at the thyroid peroxidase gene locus in solitary cold thyroid nodules. Thyroid 11:741-747
176. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R, Leung SY 2002 Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62:6451-6455
177. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457
178. Krohn K, Paschke R 2004 BRAF mutations are not an alternative explanation for the molecular etiology of ras-mutation negative cold thyroid nodules. Thyroid 14:359-361
179. Xing M, Vasko V, Tallini G, Larin A, Wu G, Udelsman R, Ringel MD, Ladenson PW, Sidransky D 2004 BRAF T1796A transversion mutation in various thyroid neoplasms. J Clin Endocrinol Metab 89:1365-1368
180. Puxeddu E, Moretti S, Elisei R, Romei C, Pascucci R, Martinelli M, Marino C, Avenia N, Rossi ED, Fadda G, Cavaliere A, Ribacchi R, Falorni A, Pontecorvi A, Pacini F, Pinchera A, Santeusanio F 2004 BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab 89:2414-2420
181. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M 2003 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578-4580
182. Esapa C, Foster S, Johnson S, Jameson JL, Kendall-Taylor P, Harris PE 1997 G protein and thyrotropin receptor mutations in thyroid neoplasia. J Clin Endocrinol Metab 82:493-496
183. q in thyroid neoplasia. J Clin Endocrinol Metab 83:554-559
184. Vanvooren V, Allgeier A, Nguyen M, Massart C, Parma J, Dumont JE, Van Sande J 2001 Mutation analysis of the Epac-Rap1 signaling pathway in cold thyroid follicular adenomas. Eur J Endocrinol 144:605-610
185. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey III TJ 2003 Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9:1792-1800
186. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, de la Chappelle A 2001 Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98:15044-15049
187. Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C 2003 Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63:2864-2871
188. Xu J, Moatamed F, Caldwell JS, Walker JR, Kraiem Z, Taki K, Brent GA, Hershman JM 2003 Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. J Clin Endocrinol Metab 88:4990-4996
189. Krohn K, Stricker I, Emmrich P, Paschke R 2003 Cold thyroid nodules show a marked increase of proliferation markers. Thyroid 13:569-576
190. Stoler DL, Datta RV, Charles MA, Block AW, Brenner BM, Sieczka EM, Hicks Jr WL, Loree TR, Anderson GR 2002 Genomic instability measurement in the diagnosis of thyroid neoplasms. Head Neck 24:290-295
191. Dobosz T, Lukienczuk T, Sasiadek M, Kuczymarknska A, Jankowska E, Blin N 2000 Microsatellite instability in thyroid papillary carcinoma and multinodular hyperplasia. Oncology 58:305-310
192. Lang W, Georgii A, Stauch G, Kienzle E 1980 The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch A Pathol Anat Histol 385:125-141
193. Bol S, Belge G, Thode B, Bartnitzke S, Bullerdiek J 1999 Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature. Cancer Genet Cytogenet 114:75-77
194. Rippe V, Drieschner N, Meiboom M, Murua EH, Bonk U, Belge G, Bullerdiek J 2003 Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas. Oncogene 22:6111-6114
195. Ward LS, Brenta G, Medvedovic M, Fagin JA 1998 Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab 83:525-530
196. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 289:1357-1360
197. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, Leite V 2002 Expression of PAX8-PPARγ1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87:3947-3952
198. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, Tallini G, Kroll TG, Nikiforov YE 2003 RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326
199. Dwight T, Thoppe SR, Foukakis T, Lui WO, Wallin G, Hoog A, Frisk T, Larsson C, Zedenius J 2003 Involvement of the PAX8/peroxisome proliferator-activated receptor γ rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab 88:4440-4445
200. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE 2002 PAX8-PPARγ rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 26:1016-1023
201. Wiersinga WM 1992 Determinants of outcome in sporadic nontoxic goiter. Thyroidology 4:41-43
202. Vanderpump MPJ, Tunbridge WMG 1996 The epidemiology of thyroid diseases. In: Braverman LE, Utiger R, eds. The thyroid. Philadelphia: Lippincott; 474-482
203. Denef JF, Haumont S, Cornette C, Beckers C 1981 Correlated functional and morphometric study of thyroid hyperplasia induced by iodine deficiency. Endocrinology 108:2352-2358
204. Van Middlesworth L 1986 T-2 mycotoxin intensifies iodine deficiency in mice fed low iodine diet. Endocrinology 118:583-586
205. - uptake by thyrotropin through the cyclic adenosine 3′,5′-monophosphate cascade. Endocrinology 136:965-973
206. Wiseman H, Halliwell B 1996 Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313:17-29
207. Abs R, Stevenaert A, Beckers A 1994 Autonomously functioning thyroid nodules in a patient with a thyrotropin-secreting pituitary adenoma: possible cause-effect relationship. Eur J Endocrinol 131:355-358
208. Studer H, Huber G, Derwahl M, Frey P 1989 [The transformation of Basedow's struma into nodular goiter: a reason for recurrence of hyperthyroidism]. Schweiz Med Wochenschr 119:203-208 (German)
209. Cheung NW, Boyages SC 1997 The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46:545-549
210. Dumont JE, Ermans AM, Maenhaut C, Coppee F, Stanbury JB 1995 Large goitre as a maladaptation to iodine deficiency. Clin Endocrinol (Oxf) 43:1-10
211. Hadjidakis S, Koutras DA, Daikos G 1964 Endemic goitre in Greece: family studies. J Med Genet 82:82-87
212. Malamos B, Koutras DA, Kostamis P, Kralios AC, Rigopoulos G, Zerefos N 1966 Endemic goiter in Greece: epidemiologic and genetic studies. J Clin Endocrinol Metab 26:688-695
213. Malamos B, Koutras DA, Kostamis P 1967 Endemic goitre in Greece: a study of 379 twin pairs. J Med Genet 4:16-18
214. Tajtakova M, Langer P, Gonsorcikova V, Bohov, Hancinova D 1998 Recognition of a subgroup of adolescents with rapidly growing thyroids under iodine-replete conditions: seven year follow-up. Eur J Endocrinol 138:674-680
215. Abuye C, Omwega AM, Imungi JK 1999 Familial tendency and dietary association of goitre in Gamo-Gofa, Ethiopia. East Afr Med J 76:447-451
216. Langer P, Tajtakova M, Bohov P, Klimes I 1999 Possible role of genetic factors in thyroid growth rate and in the assessment of upper limit of normal thyroid volume in iodine-replete adolescents. Thyroid 9:557-562
217. Doufas AG, Mastorakos G, Chatziioannou S, Tseleni-Balafouta S, Piperingos G, Boukis MA, Mantzos E, Caraiskos CS, Mantzos J, Alevizaki M, Koutras DA 1999 The predominant form of nontoxic goiter in Greece is now autoimmune thyroiditis. Eur J Endocrinol 140:505-511
218. Heimann P 1966 Familial incidence of thyroid disease and anamnestic incidence of pubertal struma in 449 consecutive struma patients. Acta Med Scand 179:113-119
219. Greig WR, Boyle JA, Duncan A, Nicol J, Gray MJ, Buchanan WW, McGirr EM 1967 Genetic and non-genetic factors in simple goitre formation: evidence from a twin study. Q J Med 142:175-188
220. Brix TH, Kyvik KO, Hegedüs L 1999 Major role of genes in the etiology of simple goiter in females: a population-based twin study. J Clin Endocrinol Metab 84:3071-3075
221. Medeiros-Neto G, Targovnik H, Knobel M, Propato F, Varela V, Alkmin M, Barbosa S, Wajchenberg BL 1989 Qualitative and quantitative defects of thyroglobulin resulting in congenital goiter. Absence of gross gene deletion of coding sequences in the TG gene structure. J Endocrinol Invest 12:805-813
222. Targovnik HM, Cochaux P, Corach D, Vassart G 1992 Identification of a minor Tg mRNA transcript in RNA from normal and goitrous thyroids. Mol Cell Endocrinol 84:R23-R26
223. Targovnik HM, Medeiros-Neto G, Varela V, Cochaux P, Wajchenberg BL, Vassart G 1993 A nonsense mutation causes human hereditary congenital goiter with preferential production of a 171-nucleotide-deleted thyroglobulin ribonucleic acid messenger. J Clin Endocrinol Metab 77:210-215
224. Targovnik HM, Frechtel GD, Mendive FM, Vono J, Cochaux P, Vassart G, Medeiros-Neto G 1998 Evidence for the segregation of three different mutated alleles of the thyroglobulin gene in a Brazilian family with congenital goiter and hypothyroidism. Thyroid 8:291-297
225. Ieiri T, Cochaux P, Targovnik HM, Suzuki M, Shimoda S, Perret J, Vassart G 1991 A 3′ splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 88:1901-1905
226. Hishinuma A, Takamatsu J, Ohyama Y, Yokozawa T, Kanno Y, Kuma K, Yoshida S, Matsuura N, Ieiri T 1999 Two novel cysteine substitutions (C1263R and C1995S) of thyroglobulin cause a defect in intracellular transport of thyroglobulin in patients with congenital goiter and the variant type of adenomatous goiter. J Clin Endocrinol Metab 84:1438-1444
227. van de Graaf SA, Cammenga M, Ponne NJ, Veenboer GJ, Gons MH, Orgiazzi J, De Vijlder JJ, Ris-Stalpers C 1999 The screening for mutations in the thyroglobulin cDNA from six patients with congenital hypothyroidism. Biochimie 81:425-432
228. Targovnik HM, Rivolta CM, Mendive FM, Moya CM, Vono J, Medeiros-Neto G 2001 Congenital goiter with hypothyroidism caused by a 5′ splice site mutation in the thyroglobulin gene. Thyroid 11:685-690
229. Hishinuma A, Kasai K, Masawa N, Kanno Y, Arimura M, Shimoda SI, Ieiri T 1998 Missense mutation (C1263R) in the thyroglobulin gene causes congenital goiter with mild hypothyroidism by impaired intracellular transport. Endocr J 45:315-327
230. Yoshida S, Takamatsu J, Kuma K, Murakami Y, Sakane S, Katayama S, Tarutani O, Ohsawa N 1996 A variant of adenomatous goiter with characteristic histology and possible hereditary thyroglobulin abnormality. J Clin Endocrinol Metab 81:1961-1966
231. Kim PS, Hossain SA, Park YN, Lee I, Yoo SE, Arvan P 1998 A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases. Proc Natl Acad Sci USA 95:9909-9913
232. Corral J, Martin C, Perez R, Sanchez I, Mories MT, San Millan JL, Miralles JM, Gonzalez-Sarmiento R 1993 Thyroglobulin gene point mutation associated with non-endemic simple goitre. Lancet 341:462-464
233. Perez-Centeno C, Gonzalez-Sarmiento R, Mories MT, Corrales JJ, Miralles-Garcia JM 1996 Thyroglobulin exon 10 gene point mutation in a patient with endemic goiter. Thyroid 6:423-427
234. Gonzalez-Sarmiento R, Corral J, Mories MT, Corrales JJ, Miguel-Velado E, Miralles-Garcia JM 2001 Monoallelic deletion in the 5′ region of the thyroglobulin gene as a cause of sporadic nonendemic simple goiter. Thyroid 11:789-793
235. Abramowicz MJ, Targovnik HM, Varela V, Cochaux P, Krawiec L, Pisarev MA, Propato FV, Juvenal G, Chester HA, Vassart G 1992 Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest 90:1200-1204
236. Bakker B, Bikker H, Vulsma T, de Randamie JS, Wiedijk BM, De Vijlder JJ 2000 Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab 85:3708-3712
237. Bikker H, Baas F, De Vijlder JJ 1997 Molecular analysis of mutated thyroid peroxidase detected in patients with total iodide organification defects. J Clin Endocrinol Metab 82:649-653
238. Bikker H, Waelkens JJ, Bravenboer B, De Vijlder JJ 1996 Congenital hypothyroidism caused by a premature termination signal in exon 10 of the human thyroid peroxidase gene. J Clin Endocrinol Metab 81:2076-2079
239. Bikker H, Vulsma T, Baas F, De Vijlder JJ 1995 Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis. Hum Mutat 6:9-16
240. Bikker H, den Hartog MT, Baas F, Gons MH, Vulsma T, De Vijlder JJ 1994 A 20-basepair duplication in the human thyroid peroxidase gene results in a total iodide organification defect and congenital hypothyroidism. J Clin Endocrinol Metab 79:248-252
241. Hagen GA, Niepomniszcze H, Haibach H, Bigazzi M, Hati R, Rapoport B, Jimenez C, DeGroot LJ, Frawley TF 1971 Peroxidase deficiency in familial goiter with iodide organification defect. N Engl J Med 285:1394-1398
242. Pommier J, Tourniaire J, Deme D, Chalendar D, Bornet H, Nunez J 1974 A defective thyroid peroxidase solubilized from a familial goiter with iodine organification defect. J Clin Endocrinol Metab 39:69-80
243. Pannain S, Weiss RE, Jackson CE, Dian D, Beck JC, Sheffield VC, Cox N, Refetoff S 1999 Two different mutations in the thyroid peroxidase gene of a large inbred Amish kindred: power and limits of homozygosity mapping. J Clin Endocrinol Metab 84:1061-1071
244. Niu DM, Hwang B, Chu YK, Liao CJ, Wang PL, Lin CY 2002 High prevalence of a novel mutation (2268 insT) of the thyroid peroxidase gene in Taiwanese patients with total iodide organification defect, and evidence for a founder effect. J Clin Endocrinol Metab 87:4208-4212
245. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM 1996 Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 226:339-345
246. Shen DH, Kloos RT, Mazzaferri EL, Jhian SM 2001 Sodium iodide symporter in health and disease. Thyroid 11:415-425
247. Kosugi S, Bhayana S, Dean HJ 1999 A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect. J Clin Endocrinol Metab 84:3248-3253
248. Kotani T, Umeki K, Yamamoto I, Maesaka H, Tachibana K, Ohtaki S 1999 A novel mutation in the human thyroid peroxidase gene resulting in a total iodide organification defect. J Endocrinol 160:267-273
249. - symporter. Nat Genet 16:124-125
250. Kosugi S, Inoue S, Matsuda A, Jhiang SM 1998 Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients. J Clin Endocrinol Metab 83:3373-3376
251. - symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism. FEBS Lett 429:36-40
252. - symporter in patients with iodide transport defect. J Clin Endocrinol Metab 83:2940-2943
253. Matsuda A, Kosugi S 1997 A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 82:3966-3971
254. Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, Refetoff S 1998 Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3′ splice site. J Clin Invest 101:1028-1035
255. Pohlenz J, Refetoff S 1999 Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism. Biochimie 81:469-476
256. Reardon W, Trembath RC 1996 Pendred syndrome. J Med Genet 33:1037-1040
257. Kopp P 1999 Pendred's syndrome: identification of the genetic defect a century after its recognition. Thyroid 9:65-69
258. Medeiros-Neto G, Stanbury JB 1994 Pendred's Syndrom: association of congenital deafness with sporadic goiter. In: Medeiros-Neto G, Stanbury JB, eds. Inherited disorders of the thyroid system. Boca Raton, FL: CRC Press; 81-105
259. Illum P, Kiaer HW, Hvidberg-Hansen J, Sondergaard G 1972 Fifteen cases of Pendred's syndrome. Congenital deafness and sporadic goiter. Arch Otolaryngol 96:297-304
260. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED 1997 Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17:411-422
261. Kopp P, Arseven OK, Sabacan L, Kotlar T, Dupuis J, Cavaliere H, Santos CL, Jameson JL, Medeiros-Neto G 1999 Phenocopies for deafness and goiter development in a large inbred Brazilian kindred with Pendred's syndrome associated with a novel mutation in the PDS gene. J Clin Endocrinol Metab 84:336-341
262. Van Hauwe P, Everett LA, Coucke P, Scott DA, Kraft ML, Ris-Stalpers C, Bolder C, Otten B, De Vijlder JJ, Dietrich NL, Ramesh A, Srisailapathy SC, Parving A, Cremers CW, Willems PJ, Smith RJ, Green ED, Van Camp G 1998 Two frequent missense mutations in Pendred syndrome. Hum Mol Genet 7:1099-1104
263. Campbell C, Cucci RA, Prasad S, Green GE, Edeal JB, Galer CE, Karniski LP, Sheffield VC, Smith RJ 2001 Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat 17:403-411
264. de Roux N, Misrahi M, Chatelain N, Gross B, Milgrom E 1996 Microsatellites and PCR primers for genetic studies and genomic sequencing of the human TSH receptor gene. Mol Cell Endocrinol 117:253-256
265. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB, Morris JC 1999 Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab 84:3328-3335
266. Nogueira CR, Kopp P, Arseven OK, Santos CL, Jameson JL, Medeiros-Neto G 1999 Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil. Thyroid 9:1063-1068
267. Mühlberg T, Herrmann K, Joba W, Kirchberger M, Heberling HJ, Heufelder AE 2000 Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population. J Clin Endocrinol Metab 85:2640-2643
268. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG, Visser TJ 2003 Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88:2880-2888
269. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, Goldgar DE, Romeo G, Houlston RS, Narod SA, Stratton MR, Foulkes WD 1997 Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123-1130
270. - symporter. J Clin Endocrinol Metab 84:3750-3756
271. Capon F, Tacconelli A, Giardina E, Sciacchitano S, Bruno R, Tassi V, Trischitta V, Filetti S, Dallapiccola B, Novelli G 2000 Mapping a dominant form of multinodular goiter to chromosome Xp22. Am J Hum Genet 67:1004-1007
272. Neumann S, Bayer Y, Reske A, Tajtakova M, Langer P, Paschke R 2003 Further indications for genetic heterogeneity of euthyroid familial goiter. J Mol Med 81:736-745
273. Bayer Y, Neumann S, Meyer B, Rüschendorf F, Reske A, Brix TH, Hegedüs L, Langer P, Nürnberg P, Paschke R 2004 Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. J Clin Endocrinol Metab 89:4044-4052
274. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA 1987 Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70-75
275. Cheung PS, Lee JM, Boey JH 1989 Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 13:818-821
276. Reverter JL, Lucas A, Salinas I, Audi L, Foz M, Sanmarti A 1992 Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25-28
277. Mainini E, Martinelli I, Morandi G, Villa S, Stefani I, Mazzi C 1995 Levothyroxine suppressive therapy for solitary thyroid nodule. J Endocrinol Invest 18:796-799
278. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G 1997 Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7:691-697
279. Zelmanovitz F, Genro S, Gross JL 1998 Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881-3885
280. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM 2002 Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941-1946
281. Brauer VF, Hentschel B, Paschke R 2003 [Euthyroid thyroid nodules. Aims, results and perspectives concerning drug therapy]. Dtsch Med Wochenschr 128:2381-2387 (German)
282. Carrillo JF, Frias-Mendivil M, Ochoa-Carrillo FJ, Ibarra M 2000 Accuracy of fine-needle aspiration biopsy of the thyroid combined with an evaluation of clinical and radiologic factors. Otolaryngol Head Neck Surg 122:917-921
283. Cappelli C, Agosti B, Tironi A, Morassi ML, Pelizzari G, Cumetti D, Cerudelli B 2002 [Prevalence and aggressiveness of thyroid carcinoma with diameter less than one centimetre in iodine deficiency areas]. Minerva Endocrinol 27:65-71 (Italian)
284. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B 1997 Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589-1593
285. Daniels GH 1996 Thyroid nodules and nodular thyroids: a clinical overview. Compr Ther 22:239-250
286. Richter B, Neises G, Clar C 2002 Pharmacotherapy for thyroid nodules. A systematic review and meta-analysis. Endocrinol Metab Clin North Am 31:699-722
287. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY 1996 Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278-4289
288. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252
289. Grussendorf M 1996 [Therapy of euthyroid iron deficiency goiter. Effectiveness of a combination of L-thyroxine and 150 micrograms iodine in comparison with mono-L-thyroxine]. Med Klin (Munich) 91:489-493 (German)
290. Klemenz B, Forster G, Wieler H, Kahaly G, Kaiser KP, Hansen C, Willkomm P, Ruhlmann J 1998 [Combination therapy of endemic goiter with two different thyroxine/iodine combinations]. Nuklearmedizin 37:101-106 (German)
291. Saller B, Hoermann R, Ritter MM, Morell R, Kreisig T, Mann K 1991 Course of thyroid iodine concentration during treatment of endemic goitre with iodine and a combination of iodine and levothyroxine. Acta Endocrinol (Copenh) 125:662-667
292. Oertel YC 2002 A pathologist trying to help endocrinologists to interpret cytopathology reports from thyroid aspirates. J Clin Endocrinol Metab 87:1459-1461
293. Belfiore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R 1987 The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 60:3096-3102
294. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A 1995 Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1-8
295. Ridgway EC 1998 Medical treatment of benign thyroid nodules: have we defined a benefit? Ann Intern Med 128:403-405
296. Kahaly GJ, Dietlein M 2002 Cost estimation of thyroid disorders in Germany. Thyroid 12:909-914
297. Gharib H 1997 Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 26:777-800
298. Castro MR, Gharib H 2000 Thyroid nodules and cancer. When to wait and watch, when to refer. Postgrad Med 107:113-116, 119-120, 123-124
299. Wiersinga WM 1995 Is repeated fine-needle aspiration cytology indicated in (benign) thyroid nodules? Eur J Endocrinol 132:661-662
300. Erdogan MF, Kamel N, Aras D, Akdogan A, Baskal N, Erdogan G 1998 Value of re-aspirations in benign nodular thyroid disease. Thyroid 8:1087-1090
301. Hamburger JI 1994 Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J Clin Endocrinol Metab 79:335-339
302. Baloch ZW, LiVolsi VA 2002 Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143-150
303. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O 2001 Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644-1650
304. de Micco C, Ruf J, Chrestian MA, Gros N, Henry JF, Carayon P 1991 Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissues. Cancer 67:3036-3041
305. Fagin JA 2002 Perspective: lessons learned from molecular genetic studies of thyroid cancer-insights into pathogenesis and tumor-specific therapeutic targets. Endocrinology 143:2025-2028
306. Korstanje R, Paigen B 2002 From QTL to gene: the harvest begins. Nat Genet 31:235-236
307. Eszlinger M, Krohn K, Berger K, Lauter J, Kropf S, Beck M, Fuhner D, Paschke R 2005 Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J Clin Endocrinol Metab 90:1163-1170